TWST
Twist Bioscience Corporation
$32.89
+$1.72(+5.52%)
58
Overall
60
Value
50
Tech
65
Quality
Market Cap
$1.68B
Volume
1.16M
52W Range
$24.07 - $55.33
Target Price
$39.43
Order:
Income Statement
| Metric | Trend | Chart | 2019 Sep | 2020 Sep | 2021 Sep | 2022 Sep | 2023 Sep | 2024 Sep |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $54.4M | $90.1M | $132.3M | $203.6M | $245.1M | $313.0M | ||
| Total Revenue | $54.4M | $90.1M | $132.3M | $203.6M | $245.1M | $313.0M | ||
| COST OF GOODS SOLD | ||||||||
| Cost of Revenue | $47.4M | $61.4M | $80.6M | $119.3M | $155.4M | $179.6M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $7.0M | $28.7M | $51.7M | $84.2M | $89.7M | $133.3M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $115.8M | $146.3M | $205.0M | $333.3M | $296.6M | $309.3M | ||
| Research & Development | $35.7M | $43.0M | $69.1M | $120.3M | $106.9M | $90.9M | ||
| Research Expense | $35.7M | $43.0M | $69.1M | $120.3M | $106.9M | $90.9M | ||
| Selling, General & Administrative | $80.1M | $103.3M | $135.9M | $212.9M | $189.7M | $218.4M | ||
| Selling & Marketing Expenses | $1.3K | $1.2M | $2.5M | $2.4M | $2.9M | $5.2M | ||
| General & Administrative Expenses | $80.1M | $103.3M | $135.9M | $212.9M | $189.7M | $218.4M | ||
| Promotion & Advertising | $1.3K | $1.2M | $2.5M | -- | -- | -- | ||
| Salaries & Wages | $47.4M | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $6.1M | $6.7M | $9.8M | $16.5M | $24.1M | $27.3M | ||
| Depreciation & Amortization | $6.1M | $6.7M | $9.8M | -- | -- | -- | ||
| Amortization | -- | $1.1M | $22.4M | $85.8M | $85.8M | $85.8M | ||
| Other Operating Expenses | $-1.0M | $-1.4M | $-2.7M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||
| Operating income | $-108.8M | $-140.1M | $-152.7M | $-234.8M | $-217.2M | $-220.8M | ||
| EBITDA | $-100.9M | $-132.1M | $-143.9M | $-211.7M | $-174.2M | $-176.7M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $1.3M | $787.0K | $367.0K | $80.0K | $5.0K | $29.0K | ||
| Intinc | $3.0M | $1.5M | $435.0K | $3.1M | $14.4M | $15.3M | ||
| Net Non-Operating Interest Income/Expense | $1.7M | $712.0K | $68.0K | $3.0M | $14.4M | $15.3M | ||
| Other Income/Expense | $47.7M | $61.6M | $1.4M | $17.8M | $667.0K | $2.6M | ||
| Other Special Charges | $-265.0K | $-182.0K | $-1.4M | $-1.1M | $-667.0K | $-2.6M | ||
| SPECIAL ITEMS | ||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | $9.4M | -- | ||
| Special Income Charges | -- | $-22.5M | $-80.6M | -- | $-16.2M | $-44.9M | ||
| Impairment of Capital Assets | -- | -- | -- | -- | $6.8M | $44.9M | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-106.1M | $-138.8M | $-153.7M | $-228.2M | $-203.5M | $-208.1M | ||
| Pre-Tax Income | $-107.4M | $-139.5M | $-154.0M | $-228.3M | $-203.5M | $-208.2M | ||
| INCOME TAX | ||||||||
| Tax Provision | $292.0K | $382.0K | $-1.9M | $-10.4M | $1.2M | $560.0K | ||
| NET INCOME | ||||||||
| Net Income | $-107.7M | $-139.9M | $-152.1M | $-217.9M | $-204.6M | $-208.7M | ||
| Net Income (Continuing Operations) | $-107.7M | $-139.9M | $-152.1M | $-217.9M | $-204.6M | $-208.7M | ||
| Net Income (Discontinued Operations) | $-107.7M | $-139.9M | $-152.1M | $-217.9M | $-204.6M | $-208.7M | ||
| Net Income (Common Stockholders) | $-107.7M | $-139.9M | $-152.1M | $-217.9M | $-204.6M | $-208.7M | ||
| Normalized Income | -- | -- | -- | -- | -- | $-161.2M | ||
| TOTALS | ||||||||
| Total Expenses | $163.2M | $207.7M | $285.6M | $452.6M | $452.0M | $488.9M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $27.5B | $39.2K | $48.3M | $53.9M | $56.9M | $58.0M | ||
| Average Shares Outstanding (Diluted) | $27.5B | $39.2K | -- | $53.9M | $56.9M | $58.0M | ||
| Shares Outstanding | $33.1M | $45.2M | $49.6M | $56.6M | $57.7M | $59.4M | ||
| Basic EPS | $-3.92 | $-3.57 | $-3.15 | $-4.04 | $-3.6 | $-3.6 | ||
| Basic EPS (Continuing Operations) | $-3.92 | $-3.57 | $-3.15 | $-4.04 | $-3.6 | $-3.6 | ||
| Diluted EPS | $-3.92 | $-3.57 | $-3.15 | $-4.04 | $-3.6 | $-3.6 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-4.04 | $-3.6 | $-3.6 | ||
| OTHER METRICS | ||||||||
| Fees | -- | $-61.4M | -- | -- | -- | -- | ||
| Gain On Sale Of Business | -- | -- | -- | $4.6M | -- | -- | ||
| Non Recurring Operation Expense | -- | $22.5M | -- | -- | -- | -- | ||
| Other Gand A | $80.1M | $103.3M | $135.9M | $212.9M | $189.7M | $218.4M | ||
| Other Write Down | -- | $61.4M | -- | -- | -- | -- | ||
| Other Write Off | $47.4M | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $4.9M | -- | -- | -- | -- | -- | ||
| Write Off | -- | -- | $80.6M | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | $9.4M | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TWST | $32.89 | +5.5% | 1.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Twist Bioscience Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW